Marybeth Devine
Avid Radiopharmaceuticals
14 Papers
59 Citations
Marybeth Devine is an academic researcher from Avid Radiopharmaceuticals. The author has contributed to research in topics: Myocardial perfusion imaging & Imaging agent. The author has an hindex of 6, co-authored 14 publications.
Chat about Author
Papers
Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes
Adam S. Fleisher,Michael J. Pontecorvo,Michael D. Devous,Ming Lu,Anupa Arora,Stephen P Truocchio,Patricia Aldea,Matthew Flitter,Tricia Locascio,Marybeth Devine,Andrew Siderowf,Thomas G. Beach,Thomas J. Montine,Geidy E. Serrano,Craig Curtis,Allison Perrin,Stephen Salloway,Misty Daniel,Charles Wellman,Abhinay D. Joshi,David J. Irwin,Val J. Lowe,William W. Seeley,Milos D. Ikonomovic,Joseph C. Masdeu,Ian Kennedy,Thomas S. Harris,Michael Navitsky,Sudeepti Southekal,Mark A. Mintun,A Study Investigators +30 more
TL;DR: The findings suggest that PET imaging with [18F]flortaucipir could be used to identify the density and distribution of AD-type tau pathology and the presence of high levels of AD neuropathological change.
Phase II Safety and Clinical Comparison With Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging for Detection of Coronary Artery Disease: Flurpiridaz F 18 Positron Emission Tomography
Daniel S. Berman,Jamshid Maddahi,Balaji Tamarappoo,Johannes Czernin,Raymond Taillefer,James E. Udelson,C. Michael Gibson,Marybeth Devine,Joel Lazewatsky,Gajanan Bhat,Dana Washburn +10 more
TL;DR: PET MPI with flurpiridaz F 18 was safe and superior to SPECT MPI for image quality, interpretative certainty, and overall CAD diagnosis.
182
Phase I, First-in-Human Study of BMS747158, a Novel 18F-Labeled Tracer for Myocardial Perfusion PET: Dosimetry, Biodistribution, Safety, and Imaging Characteristics After a Single Injection at Rest
Jamshid Maddahi,Johannes Czernin,Joel Lazewatsky,Sung-Cheng Huang,Magnus Dahlbom,H. Schelbert,Richard B. Sparks,Alexander Ehlgen,Paul D. Crane,Qi Zhu,Marybeth Devine,Michael E. Phelps +11 more
TL;DR: Preliminary data suggest that 18F-labeled BMS747158 appears to be well tolerated and has a unique potential for myocardial perfusion PET.
124
Patent
Methods and apparatus for synthesizing imaging agents, and intermediates thereof
Richard R. Cesati,Edward H. Cheesman,Joel Lazewatsky,Radeke Heike S,Castner James F,Mongeau Enrico,Dianne D. Zdankiewicz,Siegler Robert Wilburn,Marybeth Devine +8 more
- 08 Feb 2011
TL;DR: In this paper, the authors present methods and systems for the synthesis of imaging agents, including imaging agents comprising a radioisotope (e.g., 18F), and precursors thereof.
23
•Journal Article
Comparison of flurpiridaz F 18 PET injection and Tc-99m labeled SPECT myocardial perfusion imaging for identifying severity and extent of stress induced myocardial ischemia in phase 2 clinical trials
Jamshid Maddahi,Johannes Czernin,Daniel S. Berman,Raymond Taillefer,Marybeth Devine,Joel Lazewatsky,Gajanan Bhat,Dana Washburn +7 more
TL;DR: In this paper, rest-stress flurpiridaz F 18 PET and SPECT MPI were compared for evaluation of stress induced myocardial perfusion abnormalities in patients with coronary artery disease (CAD).
7